Another thing supporting this company is the rise in the incidence of pancreatic cancer. Twenty years ago it was rare to hear of it - in the last decade I've personally known 3 people who died (and quickly) from it. Even if OSL can market something that gives people a little more time and a little less pain, there is a growing need.
I found this from the Pancreatic Cancer Action Network online website:
The Pancreatic Cancer Action Network has released a special report called, The Alarming Rise of Pancreatic Cancer Deaths in the United States: Why We Need to Stem the Tide Today. This report was written by the organization's Research and Scientific Affairs team, led by our Vice President of Scientific and Medical Affairs Lynn Matrisian, PhD.
The alarming findings presented in the report include the fact that by the year 2020, and possibly as early as 2015, pancreatic cancer will move from the fourth leading cause of cancer death to the second leading cause of cancer death in the United States.
OSL Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)